发明名称 METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
摘要 The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
申请公布号 US2014199718(A1) 申请公布日期 2014.07.17
申请号 US201414224933 申请日期 2014.03.25
申请人 The Washington University 发明人 Bateman Randall John;Holtzman David Michael
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method for measuring the in vivo metabolism of a protein in a subject, the protein being synthesized in the central nervous system, the method comprising: (a) administering a labeled moiety to the subject, the labeled moiety being capable of crossing the blood brain barrier and incorporating into the protein as the protein is synthesized in the central nervous system of the subject; (b) obtaining a biological sample from the subject, the biological sample comprising a protein fraction labeled with the moiety and a protein fraction not labeled with the moiety; and (c) detecting the amount of labeled protein and the amount of unlabeled protein, wherein the ratio of labeled protein to unlabeled protein is directly proportional to the metabolism of the protein in the subject.
地址 St. Louis MO US